Yongwei Gu

1.3k total citations
30 papers, 1.0k citations indexed

About

Yongwei Gu is a scholar working on Molecular Biology, Pharmaceutical Science and Biomedical Engineering. According to data from OpenAlex, Yongwei Gu has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Pharmaceutical Science and 9 papers in Biomedical Engineering. Recurrent topics in Yongwei Gu's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Advancements in Transdermal Drug Delivery (7 papers). Yongwei Gu is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Advancements in Transdermal Drug Delivery (7 papers). Yongwei Gu collaborates with scholars based in China, Macao and Singapore. Yongwei Gu's co-authors include Jiyong Liu, Liangdi Jiang, Xiaomeng Tang, Aixue Li, Yunan Zhao, Yue Du, Meng Yang, Ting Wang, Xin Wu and Dan Li and has published in prestigious journals such as Biomaterials, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Yongwei Gu

29 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongwei Gu China 16 535 272 219 201 161 30 1.0k
Zongguang Tai China 19 544 1.0× 310 1.1× 91 0.4× 250 1.2× 82 0.5× 71 1.2k
Warangkana Lohcharoenkal Sweden 16 503 0.9× 170 0.6× 183 0.8× 263 1.3× 200 1.2× 28 1.2k
Baoyue Ding China 18 372 0.7× 203 0.7× 160 0.7× 258 1.3× 66 0.4× 50 860
Diana Guimarães Portugal 7 470 0.9× 260 1.0× 181 0.8× 373 1.9× 49 0.3× 12 1.0k
Prarthana Rewatkar Australia 16 364 0.7× 147 0.5× 144 0.7× 191 1.0× 83 0.5× 23 867
Xiong-Bin Hu China 19 1.1k 2.0× 314 1.2× 123 0.6× 160 0.8× 492 3.1× 34 1.5k
Giovana R. Onzi Brazil 14 329 0.6× 148 0.5× 121 0.6× 147 0.7× 95 0.6× 21 982
Kaushik Kuche India 19 424 0.8× 267 1.0× 182 0.8× 389 1.9× 71 0.4× 41 1.1k
Soheil Abbaspour‐Ravasjani Iran 16 461 0.9× 274 1.0× 95 0.4× 360 1.8× 55 0.3× 23 1.0k
Virginia Campani Italy 18 727 1.4× 93 0.3× 205 0.9× 143 0.7× 497 3.1× 41 1.2k

Countries citing papers authored by Yongwei Gu

Since Specialization
Citations

This map shows the geographic impact of Yongwei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongwei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongwei Gu more than expected).

Fields of papers citing papers by Yongwei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongwei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongwei Gu. The network helps show where Yongwei Gu may publish in the future.

Co-authorship network of co-authors of Yongwei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongwei Gu. A scholar is included among the top collaborators of Yongwei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongwei Gu. Yongwei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chai, Qingqing, Min Zhang, Yongwei Gu, et al.. (2025). Engineering nanoplatforms of bacterial outer membrane vesicles to overcome cancer therapy resistance. Drug Resistance Updates. 83. 101277–101277. 2 indexed citations
2.
Gu, Yongwei, Aixue Li, Yue Zeng, et al.. (2025). Engineering hybrid nanoparticles for targeted codelivery of triptolide and CYP3A4 -siRNA against pulmonary metastatic melanoma. Science Advances. 11(30). eadv6990–eadv6990. 6 indexed citations
3.
Cai, Huanhuan, Aixue Li, Xiaomeng Tang, et al.. (2024). Application of biodegradable microsphere injections: an anticancer perspective. Materials Advances. 5(8). 3094–3112. 7 indexed citations
4.
Li, Aixue, et al.. (2024). Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication. Journal of Nanobiotechnology. 22(1). 604–604. 10 indexed citations
5.
Li, Aixue, Dan Li, Yongwei Gu, et al.. (2023). Plant-derived nanovesicles: Further exploration of biomedical function and application potential. Acta Pharmaceutica Sinica B. 13(8). 3300–3320. 65 indexed citations
6.
Zhao, Yunan, Yongwei Gu, Qi Fu, et al.. (2023). Engineering adipocytes for targeting delivery of triptolide derivative and Ce6 for malignant melanoma cytotoxic-PDT synergistic strategy. Materials & Design. 228. 111860–111860. 13 indexed citations
7.
Zhang, Pan, Chao Qin, Nan Liu, et al.. (2022). The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment. Biomaterials. 284. 121518–121518. 51 indexed citations
8.
Tang, Xiaomeng, Dan Li, Yongwei Gu, et al.. (2022). Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer. Theranostics. 12(16). 7080–7107. 12 indexed citations
9.
Jiang, Liangdi, Yongwei Gu, Yue Du, et al.. (2021). Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy. ACS Applied Materials & Interfaces. 13(36). 42411–42428. 65 indexed citations
10.
Zhao, Yunan, Aixue Li, Liangdi Jiang, Yongwei Gu, & Jiyong Liu. (2021). Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications. Biomacromolecules. 22(8). 3149–3167. 90 indexed citations
11.
12.
Tang, Xiaomeng, Meng Yang, Yongwei Gu, et al.. (2021). Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis. Drug Design Development and Therapy. Volume 15. 4105–4123. 11 indexed citations
13.
Huang, Zhiyong, Zhiqin Fu, Shuyan Tang, et al.. (2020). <p>A Novel Drug Delivery Carrier Comprised of Nimodipine Drug Solution and a Nanoemulsion: Preparation, Characterization, in vitro, and in vivo Studies</p>. International Journal of Nanomedicine. Volume 15. 1161–1172. 21 indexed citations
14.
Gu, Yongwei, Qing Gu, Qing Yang, et al.. (2020). <p>Finite Element Analysis for Predicting Skin Pharmacokinetics of Nano Transdermal Drug Delivery System Based on the Multilayer Geometry Model</p>. International Journal of Nanomedicine. Volume 15. 6007–6018. 6 indexed citations
15.
Wang, Ting, Yongwei Gu, & Jiyong Liu. (2020). Application of lipid nanocarriers in improving oral absorption of poorly soluble traditional Chinese medicine ingredients. Pharmaceutical Care and Research. 20(2). 140–144.
16.
Jiang, Liangdi, Yongwei Gu, Yue Du, & Jiyong Liu. (2019). Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer. Molecular Pharmaceutics. 16(8). 3333–3349. 123 indexed citations
17.
Gu, Yongwei, Juanjuan Ma, Zhiqin Fu, et al.. (2019). <p>Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy</p>. International Journal of Nanomedicine. Volume 14. 8805–8818. 9 indexed citations
18.
Gu, Yongwei, Meng Yang, Xiaomeng Tang, et al.. (2018). Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties. Journal of Nanobiotechnology. 16(1). 68–68. 62 indexed citations
19.
20.
Gu, Yongwei, et al.. (2013). Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat. Amino Acids. 44(4). 1215–1224. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zongguang Tai Breakdown of academic impact, for papers by Warangkana Lohcharoenkal Breakdown of academic impact, for papers by Baoyue Ding Breakdown of academic impact, for papers by Diana Guimarães Breakdown of academic impact, for papers by Prarthana Rewatkar Breakdown of academic impact, for papers by Xiong-Bin Hu Breakdown of academic impact, for papers by Giovana R. Onzi Breakdown of academic impact, for papers by Kaushik Kuche Breakdown of academic impact, for papers by Soheil Abbaspour‐Ravasjani Breakdown of academic impact, for papers by Virginia Campani
Rankless by CCL
2026